 Amy Keller
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catechin | 3 | 2022 | 26 | 2.410 |
Why?
| | Mitochondria | 7 | 2022 | 786 | 1.340 |
Why?
| | Vascular Diseases | 2 | 2022 | 241 | 1.250 |
Why?
| | Mitochondria, Muscle | 3 | 2016 | 97 | 1.110 |
Why?
| | Endothelium, Vascular | 4 | 2022 | 907 | 1.100 |
Why?
| | Glucose | 4 | 2022 | 953 | 0.880 |
Why?
| | Insulins | 1 | 2022 | 34 | 0.830 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2016 | 211 | 0.780 |
Why?
| | Glucose Intolerance | 1 | 2022 | 139 | 0.770 |
Why?
| | Nitric Oxide Synthase Type III | 5 | 2020 | 198 | 0.740 |
Why?
| | Insulin | 5 | 2022 | 2162 | 0.730 |
Why?
| | Rats, Wistar | 5 | 2022 | 399 | 0.710 |
Why?
| | Blood Vessels | 2 | 2018 | 187 | 0.680 |
Why?
| | Pterins | 1 | 2018 | 8 | 0.670 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2016 | 454 | 0.660 |
Why?
| | Homocysteine | 1 | 2019 | 137 | 0.660 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 502 | 0.650 |
Why?
| | Momordica charantia | 3 | 2014 | 14 | 0.630 |
Why?
| | Cysteine | 1 | 2019 | 184 | 0.630 |
Why?
| | Electron Transport Complex IV | 1 | 2016 | 53 | 0.570 |
Why?
| | Rats | 9 | 2022 | 5392 | 0.560 |
Why?
| | Immediate-Early Proteins | 1 | 2016 | 55 | 0.560 |
Why?
| | Menopause | 1 | 2019 | 266 | 0.550 |
Why?
| | Viral Envelope Proteins | 1 | 2016 | 80 | 0.540 |
Why?
| | Adamantane | 1 | 2015 | 16 | 0.520 |
Why?
| | Saponins | 2 | 2011 | 7 | 0.520 |
Why?
| | Dipeptides | 1 | 2015 | 51 | 0.510 |
Why?
| | Cardiovascular Diseases | 3 | 2022 | 1798 | 0.490 |
Why?
| | Oxidative Stress | 2 | 2020 | 1178 | 0.480 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 236 | 0.480 |
Why?
| | Insulin Resistance | 1 | 2022 | 1180 | 0.470 |
Why?
| | Host-Pathogen Interactions | 1 | 2016 | 300 | 0.460 |
Why?
| | Motor Activity | 2 | 2015 | 660 | 0.440 |
Why?
| | Models, Biological | 1 | 2020 | 1715 | 0.440 |
Why?
| | Aorta | 5 | 2018 | 367 | 0.430 |
Why?
| | Herpesvirus 3, Human | 1 | 2016 | 389 | 0.420 |
Why?
| | Fibroblasts | 1 | 2016 | 842 | 0.400 |
Why?
| | Plant Extracts | 2 | 2011 | 165 | 0.380 |
Why?
| | Insulin-Secreting Cells | 2 | 2011 | 330 | 0.370 |
Why?
| | Cell Respiration | 2 | 2020 | 76 | 0.350 |
Why?
| | Costus | 1 | 2008 | 1 | 0.340 |
Why?
| | Vasodilation | 3 | 2022 | 457 | 0.330 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2015 | 2174 | 0.320 |
Why?
| | Animals | 14 | 2022 | 33381 | 0.320 |
Why?
| | Nitric Oxide | 3 | 2022 | 892 | 0.320 |
Why?
| | Human Umbilical Vein Endothelial Cells | 2 | 2020 | 95 | 0.310 |
Why?
| | Superoxides | 2 | 2020 | 221 | 0.310 |
Why?
| | Postmenopause | 2 | 2019 | 305 | 0.300 |
Why?
| | Estradiol | 2 | 2019 | 476 | 0.270 |
Why?
| | Physical Conditioning, Animal | 2 | 2018 | 204 | 0.250 |
Why?
| | Signal Transduction | 3 | 2022 | 4709 | 0.220 |
Why?
| | Triterpenes | 2 | 2014 | 17 | 0.220 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2020 | 44 | 0.210 |
Why?
| | Blood Glucose | 3 | 2022 | 1939 | 0.210 |
Why?
| | Overnutrition | 1 | 2022 | 39 | 0.210 |
Why?
| | Lipids | 2 | 2022 | 607 | 0.210 |
Why?
| | Nitric Oxide Synthase | 1 | 2022 | 225 | 0.210 |
Why?
| | Respiration | 1 | 2022 | 183 | 0.200 |
Why?
| | Housing | 1 | 2022 | 123 | 0.200 |
Why?
| | Glutathione | 1 | 2022 | 324 | 0.190 |
Why?
| | Antimycin A | 1 | 2020 | 13 | 0.190 |
Why?
| | Vasoconstriction | 2 | 2018 | 213 | 0.190 |
Why?
| | Electron Transport Complex I | 1 | 2020 | 36 | 0.180 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 576 | 0.180 |
Why?
| | Cell Line | 3 | 2016 | 2707 | 0.180 |
Why?
| | Sirtuin 3 | 1 | 2020 | 60 | 0.180 |
Why?
| | Heart Diseases | 1 | 2022 | 341 | 0.170 |
Why?
| | Carbohydrates | 1 | 2018 | 59 | 0.160 |
Why?
| | Cardiorespiratory Fitness | 1 | 2018 | 39 | 0.160 |
Why?
| | Protein Kinases | 1 | 2020 | 310 | 0.160 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2018 | 75 | 0.160 |
Why?
| | Brachial Artery | 1 | 2019 | 181 | 0.160 |
Why?
| | Muscle Proteins | 1 | 2019 | 219 | 0.150 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 368 | 0.150 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 940 | 0.150 |
Why?
| | Carotid Arteries | 1 | 2018 | 184 | 0.150 |
Why?
| | Glycosides | 2 | 2014 | 34 | 0.150 |
Why?
| | Women's Health | 1 | 2019 | 274 | 0.150 |
Why?
| | Nutritional Status | 1 | 2019 | 300 | 0.140 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2022 | 468 | 0.140 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 942 | 0.140 |
Why?
| | Plants, Medicinal | 2 | 2014 | 17 | 0.140 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 226 | 0.140 |
Why?
| | Genes, Reporter | 1 | 2016 | 270 | 0.130 |
Why?
| | Cytoplasm | 1 | 2016 | 269 | 0.130 |
Why?
| | Hypoglycemic Agents | 2 | 2014 | 1032 | 0.130 |
Why?
| | Organelle Biogenesis | 1 | 2015 | 15 | 0.130 |
Why?
| | Cell Death | 1 | 2016 | 339 | 0.120 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2015 | 44 | 0.120 |
Why?
| | Fruit | 2 | 2014 | 130 | 0.120 |
Why?
| | Male | 8 | 2022 | 57801 | 0.120 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 395 | 0.120 |
Why?
| | Disease Models, Animal | 2 | 2015 | 3730 | 0.120 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2015 | 103 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 653 | 0.110 |
Why?
| | Mitochondrial Dynamics | 1 | 2013 | 27 | 0.110 |
Why?
| | Cell Nucleus | 1 | 2016 | 580 | 0.110 |
Why?
| | Fetus | 1 | 2016 | 690 | 0.100 |
Why?
| | Phytotherapy | 1 | 2011 | 69 | 0.100 |
Why?
| | Diet | 1 | 2019 | 1153 | 0.100 |
Why?
| | Seeds | 1 | 2011 | 76 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 709 | 0.100 |
Why?
| | Software | 1 | 2015 | 613 | 0.100 |
Why?
| | Obesity | 3 | 2022 | 2746 | 0.100 |
Why?
| | Protein Binding | 1 | 2016 | 1975 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2445 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2019 | 1515 | 0.090 |
Why?
| | Dominican Republic | 1 | 2008 | 20 | 0.080 |
Why?
| | Medicine, Traditional | 1 | 2008 | 23 | 0.080 |
Why?
| | Injections, Intraperitoneal | 1 | 2008 | 108 | 0.080 |
Why?
| | Mice | 4 | 2022 | 15520 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 394 | 0.080 |
Why?
| | Plant Leaves | 1 | 2008 | 118 | 0.080 |
Why?
| | PPAR gamma | 2 | 2022 | 188 | 0.070 |
Why?
| | Humans | 8 | 2022 | 118974 | 0.070 |
Why?
| | Weight Gain | 1 | 2008 | 493 | 0.070 |
Why?
| | Hyperglycemia | 1 | 2008 | 312 | 0.060 |
Why?
| | Hypertension | 1 | 2012 | 1203 | 0.060 |
Why?
| | Exercise | 1 | 2014 | 1657 | 0.060 |
Why?
| | Young Adult | 1 | 2019 | 10793 | 0.060 |
Why?
| | Lung | 1 | 2016 | 3664 | 0.060 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2014 | 144 | 0.060 |
Why?
| | Adult Children | 1 | 2022 | 18 | 0.050 |
Why?
| | Fetal Heart | 1 | 2022 | 29 | 0.050 |
Why?
| | Carnitine | 1 | 2022 | 65 | 0.050 |
Why?
| | Middle Aged | 2 | 2019 | 27617 | 0.050 |
Why?
| | Disease Progression | 1 | 2008 | 2490 | 0.050 |
Why?
| | Cardiomegaly | 1 | 2022 | 168 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2015 | 9342 | 0.050 |
Why?
| | Aged | 1 | 2019 | 19657 | 0.050 |
Why?
| | Mice, Inbred C57BL | 1 | 2008 | 4908 | 0.040 |
Why?
| | Female | 3 | 2022 | 61565 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 2018 | 76 | 0.040 |
Why?
| | Estrogen Receptor alpha | 1 | 2019 | 126 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2013 | 2478 | 0.040 |
Why?
| | Adult | 1 | 2019 | 31512 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2018 | 233 | 0.040 |
Why?
| | Sterols | 1 | 2014 | 17 | 0.030 |
Why?
| | Caco-2 Cells | 1 | 2014 | 66 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2018 | 702 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 412 | 0.030 |
Why?
| | Voltage-Dependent Anion Channel 1 | 1 | 2013 | 9 | 0.030 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2013 | 18 | 0.030 |
Why?
| | Biological Transport | 1 | 2014 | 382 | 0.030 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2013 | 48 | 0.030 |
Why?
| | Vascular Stiffness | 1 | 2018 | 425 | 0.030 |
Why?
| | Uncoupling Protein 3 | 1 | 2012 | 10 | 0.030 |
Why?
| | Rats, Mutant Strains | 1 | 2012 | 25 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2014 | 490 | 0.030 |
Why?
| | Heterozygote | 1 | 2013 | 262 | 0.030 |
Why?
| | Ion Channels | 1 | 2012 | 126 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2012 | 156 | 0.030 |
Why?
| | Gene Deletion | 1 | 2013 | 361 | 0.030 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2012 | 178 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 339 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2014 | 681 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 5691 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2012 | 371 | 0.020 |
Why?
| | Autophagy | 1 | 2013 | 315 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3588 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 240 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6412 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1489 | 0.020 |
Why?
| | Cytokines | 1 | 2012 | 1900 | 0.020 |
Why?
| | Transcription Factors | 1 | 2012 | 1570 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2019 | 12978 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|